Novel Coronavirus (SARS-CoV-2) Neutralizing Antibodies Test
Novel Coronavirus (SARS-CoV-2) Neutralizing Antibodies Test
The coronavirus family contains strains that can be contracted by humans and may cause severe respiratory illnesses.
The coronavirus outbreak that began in December 2019 is spreading rapidly throught the world and has already impacted China, Korea, Japan, Thailand, Europe, and the United States. Scientists have named the novel strain the 2019-Novel CoV or COVID-19.
Novel Coronavirus (SARS-CoV-2) Neutralizing Antibodies Test
This kit is used for in-vitro semi-quantitative determination of novel coronavirus neutralizing antibodies in human serum, plasma,venous whole blood or peripheral whole blood.
The novel coronavirus neutralizing antibodies are protective antibody produced by the human body after inoculation with novel coronavirus vaccine or infection with novel coronavirus. The kit is used to monitor the presence of neutralizing antibodies in subjects vaccinated with the novel coronavirus vaccine or in people infected with the novel coronavirus, it can be used to evaluate the immune effect after vaccination or whether neutralizing antibodies are produced in human body after infection with novel coronavirus.
download IFU: IFU AB S-RDB
download Flyer: COVID-19 S-RDB ENG
